CN109096520A - 一种改性胶原及其制备方法 - Google Patents
一种改性胶原及其制备方法 Download PDFInfo
- Publication number
- CN109096520A CN109096520A CN201810697808.8A CN201810697808A CN109096520A CN 109096520 A CN109096520 A CN 109096520A CN 201810697808 A CN201810697808 A CN 201810697808A CN 109096520 A CN109096520 A CN 109096520A
- Authority
- CN
- China
- Prior art keywords
- collagen
- modified
- modified collagen
- epigallo
- egcg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2489/00—Characterised by the use of proteins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明提供了一种改性胶原,制备方法包括以下步骤:A.由表没食子儿茶素没食子酸酯交联胶原膜;B.加载骨形态发生蛋白‑2至步骤A得到的胶原膜,清洗,干燥,即得。本发明将胶原膜以表没食子儿茶素没食子酸酯改性,再加载骨形态发生蛋白‑2,进而得到促骨再生性能良好的加载了骨形态发生蛋白‑2的表没食子儿茶素没食子酸酯改性胶原复合膜。
Description
技术领域
本发明属于生物材料领域,具体涉及一种改性胶原及其制备方法。
背景技术
牙科手术中常需要应用引导骨再生手术进行骨增量。胶原是细胞外基质的一种成分,已 经广泛应用于引导骨再生术中。胶原膜有较好的生物兼容性和较低的抗原性,并能促进成骨 细胞黏附、增殖、迁移和分化,也能有阻挡成纤维细胞快速入侵骨组织生长位点、隔开软组 织与硬组织的生长等屏障功能。
胶原(Collagen)是细胞外最重要的水不溶性纤维蛋白,是构成细胞外基质的骨架。胶原在 哺乳动物体内含量丰富,约占人体或其他动物蛋白的20%-30%。主要存在于软骨、皮肤及肌 腱等组织中,在动物体内起支持、保护及连接等多种作用。由于胶原具有良好的生物相溶性、 无毒、弱抗原性、可降解性及安全性等优点,因此可以作为天然生物材料。胶原膜作为可吸 收性膜,它具有低抗原性,生物相容性好,可参与组织愈合过程,降解速率可根据需要调节 等诸多优点。
表没食子儿茶素没食子酸酯是一种茶多酚,拥有抗癌、抗氧化、抗炎、抗纤维化和促骨 再生的作用。并且,表没食子儿茶素没食子酸酯能提高胶原的热稳定性,并保护胶原不被胶 原酶降解,因此它可以用于胶原膜的交联。
骨形态发生蛋白-2在骨引导、骨再生中有重要作用。骨形态发生蛋白-2通过促进多能干 细胞向骨再生细胞分化,从而得到促骨再生的作用。美国食品与药品监督管理局也批准了相 应的材料可以在临床上使用。
发明内容
本发明的目的是针对现有技术中存在的不足,提供一种改性胶原及其制备方法。
为了达到上述目的,本发明采用了下列技术方案:
一种改性胶原,制备方法包括以下步骤:
A.由表没食子儿茶素没食子酸酯交联胶原膜;
B.加载骨形态发生蛋白-2至步骤A得到的胶原膜,清洗,干燥,即得。
作为优选,所述的胶原膜为牛来源I型胶原制备得到。
作为优选,所述步骤A中,表没食子儿茶素没食子酸酯和胶原膜重量比为1:100。
作为优选,所述步骤A中,交联是将胶原置于表没食子儿茶素没食子酸酯中改性60min,lXPBS缓冲液冲洗。
作为优选,所述步骤A中,胶原膜是在-26℃温度下冷冻过夜;在-53℃、1Pa条件下,真 空冷冻干得到。
作为优选,所述步骤B中,加载为按照100mg:1ml的比例,将胶原膜浸泡在浓度为500ng/ml的骨形态发生蛋白-2的PBS溶液中,浸泡时间为24小时。
作为优选,所述步骤B中,干燥为将制备好的改性胶原膜置于-20℃条件下冷冻干燥过夜。
本发明的优点在于:
本发明将胶原膜以表没食子儿茶素没食子酸酯改性,再加载骨形态发生蛋白-2,进而得到促 骨再生性能良好的加载了骨形态发生蛋白-2的表没食子儿茶素没食子酸酯改性胶原复合膜。 本发明提高了以前胶原膜的生物性能,具有很好的应用前景,有望于应用在引导骨组织再生 手术(GBR)中,为引导再生术等相关增量手术提供了新选择。
具体实施方式
下面,对本发明作详细的说明。
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行 进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定 本发明。
实施例1:一种改性胶原,制备方法包括以下步骤:
A.由表没食子儿茶素没食子酸酯交联胶原膜;
B.加载骨形态发生蛋白-2至步骤A得到的胶原膜,清洗,干燥,即得。
实施例2:一种改性胶原,制备方法包括以下步骤:
A.按照重量比为1:100的比例,将表没食子儿茶素没食子酸酯和牛来源I型胶原制备的胶原 膜交联胶原膜,交联是将牛来源I型胶原置于表没食子儿茶素没食子酸酯中改性60min,lXPBS 缓冲液冲洗;
B.按照100mg:1ml的比例,将胶原膜浸泡在的骨形态发生蛋白-2浓度为500ng/ml的PBS溶 液中,浸泡时间为24小时;清洗,将制备好的改性胶原膜置于-20℃条件下冷冻干燥过夜, 即得。
本发明并不局限于前述的具体实施方式。本发明扩展到任何在本说明书中披露的新特征 或任何新的组合,以及披露的任一新的方法或过程的步骤或任何新的组合。
Claims (7)
1.一种改性胶原,其特征在于制备方法包括以下步骤:
A.由表没食子儿茶素没食子酸酯交联胶原膜;
B.加载骨形态发生蛋白-2至步骤A得到的胶原膜,清洗,干燥,即得。
2.根据权利要求1所述的一种改性胶原,其特征在于:所述的胶原膜为牛来源I型胶原制备得到。
3.根据权利要求1所述的一种改性胶原,其特征在于:所述步骤A中,表没食子儿茶素没食子酸酯和胶原膜的重量比为1:100。
4.根据权利要求1所述的一种改性胶原,其特征在于:所述步骤A中,交联是将胶原置于表没食子儿茶素没食子酸酯中改性60min,lX PBS缓冲液冲洗。
5.根据权利要求1所述的一种改性胶原,其特征在于:所述步骤A中,胶原膜是在-26℃温度下冷冻过夜;在-53℃、1Pa条件下,真空冷冻干得到。
6.根据权利要求1所述的一种改性胶原,其特征在于:所述步骤B中,加载为按照100mg:1ml的比例,将胶原膜浸泡在浓度为500ng/ml的骨形态发生蛋白-2的PBS溶液中,浸泡时间为24小时。
7.根据权利要求1所述的一种改性胶原,其特征在于:所述步骤B中,干燥为将制备好的改性胶原膜置于-20℃条件下冷冻干燥过夜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810697808.8A CN109096520A (zh) | 2018-06-29 | 2018-06-29 | 一种改性胶原及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810697808.8A CN109096520A (zh) | 2018-06-29 | 2018-06-29 | 一种改性胶原及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109096520A true CN109096520A (zh) | 2018-12-28 |
Family
ID=64845135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810697808.8A Pending CN109096520A (zh) | 2018-06-29 | 2018-06-29 | 一种改性胶原及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109096520A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114191618A (zh) * | 2021-06-01 | 2022-03-18 | 四川大学华西医院 | 一种减缓纤维化和炎性巨噬细胞募集的改性骨修复材料 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496914A (zh) * | 2008-02-03 | 2009-08-05 | 烟台正海生物技术有限公司 | 骨支架材料及其制备方法与应用 |
CN102225219A (zh) * | 2011-06-01 | 2011-10-26 | 陕西博鸿生物科技有限公司 | 一种骨组织再生引导膜及其制备方法 |
CN106390195A (zh) * | 2016-11-16 | 2017-02-15 | 四川大学 | 一种胶原膜的改性方法 |
-
2018
- 2018-06-29 CN CN201810697808.8A patent/CN109096520A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496914A (zh) * | 2008-02-03 | 2009-08-05 | 烟台正海生物技术有限公司 | 骨支架材料及其制备方法与应用 |
CN102225219A (zh) * | 2011-06-01 | 2011-10-26 | 陕西博鸿生物科技有限公司 | 一种骨组织再生引导膜及其制备方法 |
CN106390195A (zh) * | 2016-11-16 | 2017-02-15 | 四川大学 | 一种胶原膜的改性方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114191618A (zh) * | 2021-06-01 | 2022-03-18 | 四川大学华西医院 | 一种减缓纤维化和炎性巨噬细胞募集的改性骨修复材料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gaspar-Pintiliescu et al. | Natural composite dressings based on collagen, gelatin and plant bioactive compounds for wound healing: A review | |
TWI432230B (zh) | 組織支架 | |
Ruszczak | Effect of collagen matrices on dermal wound healing | |
AU667032B2 (en) | Growth factor containing matrix for the treatment of cartilage lesions | |
JP4137382B2 (ja) | 膠原組織組成物 | |
JP4223548B2 (ja) | 補足または非補足組織シーラント、それらの製法および使用 | |
US20160263279A1 (en) | Biologic replacement for fibrin clot | |
ES2959455T3 (es) | Polvo de membrana amniótica y su uso en cicatrización de heridas y en construcciones de ingeniería de tejidos | |
ES2934158T3 (es) | Biomateriales de colágeno bioactivo y métodos para su fabricación | |
Yanagibayashi et al. | Novel hydrocolloid-sheet as wound dressing to stimulate healing-impaired wound healing in diabetic db/db mice | |
CA2487042A1 (en) | Viable tissue repair implants and methods of use | |
ES2955029T3 (es) | Medicamento para la cicatrización de heridas | |
US20100331254A1 (en) | Pulverized fibrin clots and pharmaceutical compositions containing them | |
AU2019222977B2 (en) | Biomaterial for articular cartilage maintenance and treatment of arthritis | |
US20100239556A1 (en) | Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system | |
JP2018525360A (ja) | 創傷治癒、組織工学、及び再生医療のための組成物及び方法における使用のための大豆由来の生物活性ペプチド | |
CN107073170A (zh) | 用于再生口腔粘膜的生物材料支架 | |
CN105688288A (zh) | 胶原基复合口腔修复膜材料及其制备方法 | |
Shibata et al. | Development of new wound dressing composed of spongy collagen sheet containing dibutyryl cyclic AMP | |
CN109096520A (zh) | 一种改性胶原及其制备方法 | |
KR102182882B1 (ko) | 돼지 진피-유래 치과용 차폐막 및 이의 제조방법 | |
CN108404199A (zh) | 一种具有组织粘结性能的复合创伤敷料及其制备方法 | |
CN108567994A (zh) | 一种改性胶原膜及其应用 | |
Sarkar et al. | Bioactive wound dressings for the management of chronic non healing ulcers (CNHU)–A review of clinical and translational studies | |
CN112107390B (zh) | 一种复合肌腱修补材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181228 |